SLRX
Salarius Pharmaceuticals Inc
-8.52%
$2.23 - $2.04
Feb 8th 2023 - Mar 22nd 2023
Feb, 22, 2023
$RSLS shows a strong growth in Revenue.
Feb, 17, 2023
Long term growth incoming!
Feb, 16, 2023
I feel the company is heading in a direction this time around for long term and sustainable growth.
Feb, 7, 2023
$RSLS is expected to show a strong growth in EPS.
Feb, 3, 2023
Huge watcher growth!
Feb, 3, 2023
Amazing watcher growth within a single day on Stocktwits!
Mar, 21, 2023
$FSR shows a strong growth in Revenue.
Mar, 20, 2023
$FSR shows a strong growth in Revenue.
Mar, 20, 2023
Looking at the last year, $FSR shows a very strong growth in Revenue.
Mar, 20, 2023
Looking at the last year, $FSR shows a very strong growth in Revenue.
Mar, 20, 2023
Our growth will be exponential.
Mar, 19, 2023
This stock offers the growth and energy efficiency going forward.
Mar, 19, 2023
Revenue is expected to show an annual growth rate (CAGR 2023-2027) of 17.02%, resulting in a projected market volume of US$858.00bn by 2027. 🔥🍺
Mar, 17, 2023
Banks collapse and strong growth and tech have pushed!!
Mar, 17, 2023
$FSR is expected to show a strong growth in EPS.
Mar, 16, 2023
Also remember, growth will only continue from here.
Oct, 28, 2022
$SLRX SP-3164 showed significant tumor growth "inhibition" in in vivo studies including statistically significant improvement over the approved immunomodulatory drugs lenalidomide (Revlimid®) and pomalidomide (Pomalyst®)